Parallel Advisors, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7
-97.2%
4
-95.5%
0.00%
Q2 2023$252
+1160.0%
89
+2125.0%
0.00%
Q1 2023$20
-53.5%
40.0%0.00%
Q4 2022$4340.0%0.00%
Q3 2022$040.0%0.00%
Q2 2022$040.0%0.00%
Q1 2022$040.0%0.00%
Q4 2021$0
-100.0%
4
-91.7%
0.00%
Q3 2021$1,0000.0%480.0%0.00%
Q2 2021$1,0000.0%480.0%0.00%
Q1 2021$1,0000.0%480.0%0.00%
Q4 2020$1,0000.0%480.0%0.00%
Q3 2020$1,000480.0%0.00%
Q2 2020$048
+1100.0%
0.00%
Q1 2020$040.0%0.00%
Q4 2019$040.0%0.00%
Q3 2019$040.0%0.00%
Q2 2019$040.0%0.00%
Q1 2019$040.0%0.00%
Q4 2018$040.0%0.00%
Q3 2018$040.0%0.00%
Q2 2018$0
-100.0%
4
-95.6%
0.00%
Q1 2017$2,000900.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders